Versleijen-Jonkers YMH - Search Results

1

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.

Hurkmans EGE, Koenderink JB, van den Heuvel JJMW, Versleijen-Jonkers YMH, Hillebrandt-Roeffen MHS, Groothuismink JM, Vos HI, van der Graaf WTA, Flucke U, Muradjan G, Schreuder HWB, Hagleitner MM, Brunner HG, Gelderblom H, Cleton-Jansen AM, Guchelaar HJ, de Bont ESJM, Touw DJ, Nijhoff GJ, Kremer LCM, Caron H, Windsor R, Patiño-García A, González-Neira A, Saletta F, McCowage G, Nagabushan S, Catchpoole D, Te Loo DMWM, Coenen MJH. Hurkmans EGE, et al. Among authors: versleijen jonkers ymh. Front Pharmacol. 2022 Nov 9;13:1042989. doi: 10.3389/fphar.2022.1042989. eCollection 2022. Front Pharmacol. 2022. PMID: 36438828 Free PMC article.

2

ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model.

Heskamp S, van Laarhoven HW, Molkenboer-Kuenen JD, Franssen GM, Versleijen-Jonkers YM, Oyen WJ, van der Graaf WT, Boerman OC. Heskamp S, et al. J Nucl Med. 2010 Oct;51(10):1565-72. doi: 10.2967/jnumed.110.075648. Epub 2010 Sep 16. J Nucl Med. 2010. PMID: 20847162 Free article.

3

Targeted therapy for Ewing's sarcoma: significance of heterogeneity.

Van De Luijtgaarden AC, Van Der Graaf WT, Otte-Höller I, Schreuder HW, Versleijen-Jonkers YM, Slootweg PJ. Van De Luijtgaarden AC, et al. Anticancer Res. 2010 Sep;30(9):3715-9. Anticancer Res. 2010. PMID: 20944159

4

Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: the road ahead.

Van Gaal JC, De Bont ES, Kaal SE, Versleijen-Jonkers Y, van der Graaf WT. Van Gaal JC, et al. Crit Rev Oncol Hematol. 2012 Jun;82(3):259-79. doi: 10.1016/j.critrevonc.2011.06.005. Epub 2011 Jul 30. Crit Rev Oncol Hematol. 2012. PMID: 21802959 Review.

5

Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.

van Gaal JC, Flucke UE, Roeffen MH, de Bont ES, Sleijfer S, Mavinkurve-Groothuis AM, Suurmeijer AJ, van der Graaf WT, Versleijen-Jonkers YM. van Gaal JC, et al. J Clin Oncol. 2012 Jan 20;30(3):308-15. doi: 10.1200/JCO.2011.37.8588. Epub 2011 Dec 19. J Clin Oncol. 2012. PMID: 22184391

6

Prognostic and therapeutic relevance of the IGF pathway in Ewing's sarcoma patients.

van de Luijtgaarden AC, Versleijen-Jonkers YM, Roeffen MH, Schreuder HW, Flucke UE, van der Graaf WT. van de Luijtgaarden AC, et al. Target Oncol. 2013 Dec;8(4):253-60. doi: 10.1007/s11523-012-0248-3. Epub 2013 Jan 6. Target Oncol. 2013. PMID: 23292309

7

Expression and clinical relevance of MET and ALK in Ewing sarcomas.

Fleuren ED, Roeffen MH, Leenders WP, Flucke UE, Vlenterie M, Schreuder HW, Boerman OC, van der Graaf WT, Versleijen-Jonkers YM. Fleuren ED, et al. Int J Cancer. 2013 Jul 15;133(2):427-36. doi: 10.1002/ijc.28047. Epub 2013 Feb 25. Int J Cancer. 2013. PMID: 23335077 Free article.

8

The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')₂-R1507 fragments in Ewing sarcomas.

Fleuren ED, Versleijen-Jonkers YM, Heskamp S, Roeffen MH, Bouwman WH, Molkenboer-Kuenen JD, van Laarhoven HW, Oyen WJ, Boerman OC, van der Graaf WT. Fleuren ED, et al. Eur J Cancer. 2013 Sep;49(13):2851-8. doi: 10.1016/j.ejca.2013.04.009. Epub 2013 May 8. Eur J Cancer. 2013. PMID: 23664098

9

Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.

van Gaal JC, Roeffen MH, Flucke UE, van der Laak JA, van der Heijden G, de Bont ES, Suurmeijer AJ, Versleijen-Jonkers YM, van der Graaf WT. van Gaal JC, et al. Eur J Cancer. 2013 Nov;49(16):3462-70. doi: 10.1016/j.ejca.2013.06.022. Epub 2013 Jul 15. Eur J Cancer. 2013. PMID: 23867124

10

IGF signaling pathway analysis of osteosarcomas reveals the prognostic value of pAKT localization.

van de Luijtgaarden AC, Roeffen MH, Leus MA, Flucke UE, Schreuder BH, van der Graaf WT, Versleijen-Jonkers YM. van de Luijtgaarden AC, et al. Future Oncol. 2013 Nov;9(11):1733-40. doi: 10.2217/fon.13.118. Future Oncol. 2013. PMID: 24156333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page